id RCAP_9b7eae609c568bcf078ca227986be6f5
oai_identifier_str oai:repositorio.ul.pt:10451/45687
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia© 2021 Benussi A et al. JAMA Network Open. This is an open access article distributed under the terms of the CC-BY License.Importance: Behavioral disturbances are core features of frontotemporal dementia (FTD); however, symptom progression across the course of disease is not well characterized in genetic FTD. Objective: To investigate behavioral symptom frequency and severity and their evolution and progression in different forms of genetic FTD. Design, setting, and participants: This longitudinal cohort study, the international Genetic FTD Initiative (GENFI), was conducted from January 30, 2012, to May 31, 2019, at 23 multicenter specialist tertiary FTD research clinics in the United Kingdom, the Netherlands, Belgium, France, Spain, Portugal, Italy, Germany, Sweden, Finland, and Canada. Participants included a consecutive sample of 232 symptomatic FTD gene variation carriers comprising 115 with variations in C9orf72, 78 in GRN, and 39 in MAPT. A total of 101 carriers had at least 1 follow-up evaluation (for a total of 400 assessments). Gene variations were included only if considered pathogenetic. Main outcomes and measures: Behavioral and neuropsychiatric symptoms were assessed across disease duration and evaluated from symptom onset. Hierarchical generalized linear mixed models were used to model behavioral and neuropsychiatric measures as a function of disease duration and variation. Results: Of 232 patients with FTD, 115 (49.6%) had a C9orf72 expansion (median [interquartile range (IQR)] age at evaluation, 64.3 [57.5-69.7] years; 72 men [62.6%]; 115 White patients [100%]), 78 (33.6%) had a GRN variant (median [IQR] age, 63.4 [58.3-68.8] years; 40 women [51.3%]; 77 White patients [98.7%]), and 39 (16.8%) had a MAPT variant (median [IQR] age, 56.3 [49.9-62.4] years; 25 men [64.1%]; 37 White patients [94.9%]). All core behavioral symptoms, including disinhibition, apathy, loss of empathy, perseverative behavior, and hyperorality, were highly expressed in all gene variant carriers (>50% patients), with apathy being one of the most common and severe symptoms throughout the disease course (51.7%-100% of patients). Patients with MAPT variants showed the highest frequency and severity of most behavioral symptoms, particularly disinhibition (79.3%-100% of patients) and compulsive behavior (64.3%-100% of patients), compared with C9orf72 carriers (51.7%-95.8% of patients with disinhibition and 34.5%-75.0% with compulsive behavior) and GRN carriers (38.2%-100% with disinhibition and 20.6%-100% with compulsive behavior). Alongside behavioral symptoms, neuropsychiatric symptoms were very frequently reported in patients with genetic FTD: anxiety and depression were most common in GRN carriers (23.8%-100% of patients) and MAPT carriers (26.1%-77.8% of patients); hallucinations, particularly auditory and visual, were most common in C9orf72 carriers (10.3%-54.5% of patients). Most behavioral and neuropsychiatric symptoms increased in the early-intermediate phases and plateaued in the late stages of disease, except for depression, which steadily declined in C9orf72 carriers, and depression and anxiety, which surged only in the late stages in GRN carriers. Conclusions and relevance: This cohort study suggests that behavioral and neuropsychiatric disturbances differ between the common FTD gene variants and have different trajectories throughout the course of disease. These findings have crucial implications for counseling patients and caregivers and for the design of disease-modifying treatment trials in genetic FTD.This work is supported by the Joint Programme–Neurodegenerative Disease Research grant no. JPND2019-466-090 “GENFI-prox” (Drs Synofzik, van Swieten, Otto, Graff, Rohrer, and Borroni), the Centre d’Investigation Clinique grant no. ANR/DGOS PRTS 2015-2019 PREV-DEMALS (Dr Le Ber), the Centre pour l’Acquisition et le Traitement des Images platform grant no. ANR-10-IAIHU-06 (Dr Le Ber), the UK Medical Research Council grant no. MR/M023664/1 (Dr Rohrer), the Italian Ministry of Health grant no. 733051042 (Dr Galimberti), and the Canadian Institutes of Health Research as part of a Centres of Excellence in Neurodegeneration grant no. MOP 327387 (Dr Masellis), a Canadian Institutes of Health Research operating grant.American Medical AssociationRepositório da Universidade de LisboaBenussi, AlbertoPremi, EnricoGazzina, StefanoBrattini, ChiaraBonomi, ElisaAlberici, AntonellaJiskoot, Lizevan Swieten, John CSanchez-Valle, RaquelMoreno, FerminLaforce, RobertGraff, CarolineSynofzik, MatthisGalimberti, DanielaMasellis, MarioTartaglia, CarmelaRowe, James BFinger, ElizabethVandenberghe, RikDe Mendonça, AlexandreTagliavini, FabrizioSantana, IsabelDucharme, SimonButler, Chris RGerhard, AlexanderLevin, JohannesDanek, AdrianOtto, MarkusFrisoni, GiovanniGhidoni, RobertaSorbi, SandroLe Ber, IsabellePasquier, FlorencePeakman, GeorgiaTodd, EmilyBocchetta, MartinaRohrer, Jonathan DBorroni, Barbara2021-01-07T11:39:17Z2021-01-042021-01-04T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/45687engJAMA Netw Open. 2021;4(1):e2030194.10.1001/jamanetworkopen.2020.301942574-3805info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:47:39Zoai:repositorio.ul.pt:10451/45687Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:58:03.063645Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
title Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
spellingShingle Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
Benussi, Alberto
title_short Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
title_full Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
title_fullStr Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
title_full_unstemmed Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
title_sort Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia
author Benussi, Alberto
author_facet Benussi, Alberto
Premi, Enrico
Gazzina, Stefano
Brattini, Chiara
Bonomi, Elisa
Alberici, Antonella
Jiskoot, Lize
van Swieten, John C
Sanchez-Valle, Raquel
Moreno, Fermin
Laforce, Robert
Graff, Caroline
Synofzik, Matthis
Galimberti, Daniela
Masellis, Mario
Tartaglia, Carmela
Rowe, James B
Finger, Elizabeth
Vandenberghe, Rik
De Mendonça, Alexandre
Tagliavini, Fabrizio
Santana, Isabel
Ducharme, Simon
Butler, Chris R
Gerhard, Alexander
Levin, Johannes
Danek, Adrian
Otto, Markus
Frisoni, Giovanni
Ghidoni, Roberta
Sorbi, Sandro
Le Ber, Isabelle
Pasquier, Florence
Peakman, Georgia
Todd, Emily
Bocchetta, Martina
Rohrer, Jonathan D
Borroni, Barbara
author_role author
author2 Premi, Enrico
Gazzina, Stefano
Brattini, Chiara
Bonomi, Elisa
Alberici, Antonella
Jiskoot, Lize
van Swieten, John C
Sanchez-Valle, Raquel
Moreno, Fermin
Laforce, Robert
Graff, Caroline
Synofzik, Matthis
Galimberti, Daniela
Masellis, Mario
Tartaglia, Carmela
Rowe, James B
Finger, Elizabeth
Vandenberghe, Rik
De Mendonça, Alexandre
Tagliavini, Fabrizio
Santana, Isabel
Ducharme, Simon
Butler, Chris R
Gerhard, Alexander
Levin, Johannes
Danek, Adrian
Otto, Markus
Frisoni, Giovanni
Ghidoni, Roberta
Sorbi, Sandro
Le Ber, Isabelle
Pasquier, Florence
Peakman, Georgia
Todd, Emily
Bocchetta, Martina
Rohrer, Jonathan D
Borroni, Barbara
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Benussi, Alberto
Premi, Enrico
Gazzina, Stefano
Brattini, Chiara
Bonomi, Elisa
Alberici, Antonella
Jiskoot, Lize
van Swieten, John C
Sanchez-Valle, Raquel
Moreno, Fermin
Laforce, Robert
Graff, Caroline
Synofzik, Matthis
Galimberti, Daniela
Masellis, Mario
Tartaglia, Carmela
Rowe, James B
Finger, Elizabeth
Vandenberghe, Rik
De Mendonça, Alexandre
Tagliavini, Fabrizio
Santana, Isabel
Ducharme, Simon
Butler, Chris R
Gerhard, Alexander
Levin, Johannes
Danek, Adrian
Otto, Markus
Frisoni, Giovanni
Ghidoni, Roberta
Sorbi, Sandro
Le Ber, Isabelle
Pasquier, Florence
Peakman, Georgia
Todd, Emily
Bocchetta, Martina
Rohrer, Jonathan D
Borroni, Barbara
description © 2021 Benussi A et al. JAMA Network Open. This is an open access article distributed under the terms of the CC-BY License.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-07T11:39:17Z
2021-01-04
2021-01-04T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/45687
url http://hdl.handle.net/10451/45687
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv JAMA Netw Open. 2021;4(1):e2030194.
10.1001/jamanetworkopen.2020.30194
2574-3805
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Medical Association
publisher.none.fl_str_mv American Medical Association
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134525784064000